Insider Transactions in Q3 2025 at Cadrenal Therapeutics, Inc. (CVKD)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
6,790
-3.22%
|
$95,060
$14.09 P/Share
|
|
Sep 25
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,900
-36.54%
|
$152,600
$14.05 P/Share
|
|
Sep 24
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
2,581
-1.21%
|
$33,553
$13.99 P/Share
|
|
Sep 24
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,500
-4.79%
|
$21,000
$14.0 P/Share
|
|
Aug 28
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
1,193
-0.56%
|
$15,509
$13.99 P/Share
|
|
Aug 28
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
400
-1.26%
|
$5,600
$14.0 P/Share
|
|
Aug 27
2025
|
Quang X Pham CEO and Chairman |
SELL
Open market or private sale
|
Direct |
3,836
-1.76%
|
$49,868
$13.99 P/Share
|
|
Aug 27
2025
|
Matthew K Szot Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,600
-4.8%
|
$20,800
$13.99 P/Share
|